Annual Current Liabilities
$49.90 M
+$13.84 M+38.38%
December 31, 2023
Summary
- As of February 7, 2025, NAMS annual total current liabilities is $49.90 million, with the most recent change of +$13.84 million (+38.38%) on December 31, 2023.
- During the last 3 years, NAMS annual current liabilities has risen by +$34.14 million (+216.74%).
- NAMS annual current liabilities is now at all-time high.
Performance
NAMS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$41.26 M
-$4.05 M-8.94%
September 30, 2024
Summary
- As of February 7, 2025, NAMS quarterly total current liabilities is $41.26 million, with the most recent change of -$4.05 million (-8.94%) on September 30, 2024.
- NAMS quarterly current liabilities is now -30.93% below its all-time high of $59.73 million, reached on March 31, 2024.
Performance
NAMS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NAMS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.4% | - |
| 3 y3 years | +216.7% | +14.4% |
| 5 y5 years | +216.7% | +14.4% |
NAMS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +346.1% | -30.9% | +268.8% |
| 5 y | 5-year | at high | +346.1% | -30.9% | +268.8% |
| alltime | all time | at high | +346.1% | -30.9% | +268.8% |
NewAmsterdam Pharma Company NV Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.26 M(-8.9%) |
| Jun 2024 | - | $45.31 M(-24.1%) |
| Mar 2024 | - | $59.73 M(+19.7%) |
| Dec 2023 | $49.90 M | $49.90 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $41.66 M(+15.5%) |
| Dec 2022 | $36.06 M(+222.3%) | $36.06 M(+33.3%) |
| Jun 2022 | - | $27.06 M(+141.9%) |
| Dec 2021 | $11.19 M(-29.0%) | $11.19 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total current liabilities?
- What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV annual total current liabilities?
The current annual current liabilities of NAMS is $49.90 M
What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total current liabilities is $49.90 M
What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
Over the past year, NAMS annual total current liabilities has changed by +$13.84 M (+38.38%)
What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
The current quarterly current liabilities of NAMS is $41.26 M
What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total current liabilities is $59.73 M